Mayne Pharma Group Ltd (MYX) — Cash Flow Quality Index
Mayne Pharma Group Ltd (MYX) has a Cash Flow Quality Index of -0.20x as of September 2022. Operating cash flow of AU$-28.40 Million is below net income of AU$145.01 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore MYX long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Mayne Pharma Group Ltd Cash Flow Quality Index (2010–2023)
Historical Cash Flow Quality Index for Mayne Pharma Group Ltd across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Mayne Pharma Group Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Mayne Pharma Group Ltd (2010–2023)
Year-by-year earnings quality comparison for Mayne Pharma Group Ltd. For live market cap and the full company financial profile, see market cap of Mayne Pharma Group Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2023 | -0.36x | AU$-42.71 Million | AU$117.25 Million | ▼ -111.7% |
| 2017 | -0.17x | AU$-15.24 Million | AU$88.57 Million | ▼ -112.0% |
| 2016 | 1.43x | AU$53.50 Million | AU$37.35 Million | ▼ -50.4% |
| 2015 | 2.89x | AU$22.42 Million | AU$7.76 Million | ▲ +135.4% |
| 2014 | 1.23x | AU$26.14 Million | AU$21.29 Million | ▼ -43.6% |
| 2012 | 2.18x | AU$13.39 Million | AU$6.15 Million | ▼ -10.6% |
| 2011 | 2.43x | AU$4.09 Million | AU$1.68 Million | ▼ -22.8% |
| 2010 | 3.15x | AU$10.26 Million | AU$3.25 Million | — |